PMWC - Program

January 25

	Track 1	Track 2	Track 3	Track 4	Showcase Track S1	Showcase Track S2
January 25
Jan. 25 9:00 A.M.	Day1: Gene and Cell Therapies Track Welcome And Opening By Track Chairs Yael Weiss MD, PhD, CEO, Mahzi TxMahzi Tx	Day1: AI and Data Science in Clinical Practice Track How Can AI And Data Science Determine Which Patients Should Be Preemptively Tested? \| Panel Chair: Russ Cucina MD, Chief Health Information Officer & VP, Genetic & Genomic Services, UCSF HealthUCSF	Day1: Early Oncology Applications Track PMWC Award Ceremony Todd Golub MD, Dir., Founding Core Inst. Member, Broad Inst.Broad Inst.	Day1: Sequencing Techniques & Applications Track How New Public-Private Collaboratives Can Catalyze Transformative Health Breakthroughs \| Panel Chair: Keith Yamamoto PhD, Vice Chancellor for Science Policy & Strategy, UCSFUCSF	Day1: AI & Data Sciences and Genomic Profiling AI and Data Sciences Showcase Mark Mooney PhD, VP of Customer Success, Tag.bioTag.bio	Day1: Clinical Dx and Clinical & Research Tools Clinical Dx Showcase Padma Sundar CBO, ChromaCodeChromaCode
Jan. 25 9:15 A.M.	PMWC 2023 Luminary Award Ceremony Allyson Berent DVM, DACVIM, Chief Science Officer, FASTFAST Terry Pirovolakis Founder, CureSPG50CureSPG50	How Can AI And Data Science Determine Which Patients Should Be Preemptively Tested? \| Panel Sylvia Plevritis PhD, Chair of Biomedical Data Science, StanfordStanford Lisa Kroon PharmD, Assist. Chief Pharmacy Officer & Chair, Dept. of Clinical Pharmacy, UCSFUCSF	Fireside Chat: Precision Medicine - Past, Present And Future \| Panel Chair: Hakan Sakul PhD, VP, Head of Diagnostics, PfizerPfizer	How New Public-Private Collaboratives Can Catalyze Transformative Health Breakthroughs \| Panel Douglas Friedman PhD, CEO, BioMADEBioMADE Jay Keasling PhD, CEO, JBEIJBEI	AI and Data Sciences Showcase Mark Mooney PhD, VP of Customer Success, Tag.bioTag.bio	Clinical Dx Showcase Padma Sundar CBO, ChromaCodeChromaCode
Jan. 25 9:30 A.M.	From Bench To Bedside - Biomarkers, Natural History Studies, Animal Models \| Panel Chair: Peter Marks MD, PhD, Dir., CBER, FDAFDA Allyson Berent DVM, DACVIM, Chief Science Officer, FASTFAST	How Can AI And Data Science Determine Which Patients Should Be Preemptively Tested? \| Panel Eran Segal PhD, Computational Biology Prof., Weizmann Inst.Weizmann Institute	Fireside Chat: Precision Medicine - Past, Present And Future \| Panel Todd Golub MD Dir., Founding Core Inst. Member, Broad Inst.Broad Inst.	How New Public-Private Collaboratives Can Catalyze Transformative Health Breakthroughs \| Panel Renee Wegrzyn PhD, Inaugural Dir., ARPA-HARPA-H	Genomic Profiling Showcase Bani Tamraz PharmD, PhD, Assoc. Prof. Dept. of Clinical Pharmacy, UCSFUCSF	Clinical Dx Showcase Nick Goldner PhD, CEO/Co-Founder, ResistanceResistance Bio
Jan. 25 9:45 A.M.	From Bench To Bedside - Biomarkers, Natural History Studies, Animal Models \| Panel Emil Kakkis MD, PhD, Pres. & CEO, UltragenyxUltragenyx	How Can AI And Data Science Determine Which Patients Should Be Preemptively Tested? \| Panel Daniel Knecht MD, MBA, Chief Clinical Innovation Officer, CVS CaremarkCVS Caremark	Challenges In Providing Global Access To Precision Health \| Panel Chair: Michael Pellini MD, Manag. Partner, Section 32Section 32	Moving Sequencing Into The Clinical Setting \| Panel Chair: Charles Chiu MD, PhD, Prof., Laboratory Medicine & Medicine/Infectious Diseases, UCSFUCSF	Genomic Profiling Showcase Robert Balog PhD, Sr. Dir., Research & Dev., Thermo FisherThermo Fisher	Clinical Dx Showcase Nick Goldner PhD, CEO/Co-Founder, ResistanceResistance Bio
Jan. 25 10:00 A.M.	From Bench To Bedside - Biomarkers, Natural History Studies, Animal Models \| Panel Alysson Muotri PhD, Prof., UC San DiegoUCSD	Establishing Genomics In The Clinic As A Routine Requires AI And Automation Chair: Bani Tamraz PharmD, PhD, Assoc. Prof. Dept. of Clinical Pharmacy, UCSFUCSF Sergio Baranzini PhD, Prof., UCSFUCSF	Challenges In Providing Global Access To Precision Health \| Panel Steve Rosen PhD, CSO Twin Orbit, Wyss HarvardWyss Harvard Peter Kuhn PhD, Prof., USCUSC	Moving Sequencing Into The Clinical Setting \| Panel Charlotte Hobbs MD, PhD, VP, Chief Research & Clinical Management Officer, Rady Children's Inst.Rady Children's Inst. Euan Ashley MD, PhD, Assoc. Dean, StanfordStanford	Genomic Profiling Showcase Prasanth Reddy MD, MPH, FACP, Sr. VP & Global Head of Enterprise Oncology, LabcorpLabcorp	Clinical Dx Showcase Babak Alipanahi PhD, CSO, ExaiExai
Jan. 25 10:15 A.M.	From Bench To Bedside - Biomarkers, Natural History Studies, Animal Models \| Panel Nasha Fitter MBA, Head, Data Platforms, InvitaeInvitae	Establishing Genomics In The Clinic As A Routine Requires AI And Automation James Shalaby PharmD, CEO, Founder, Elimu InformaticsElimu	Challenges In Providing Global Access To Precision Health \| Panel Edward Abrahams PhD, Pres., PMCPMC Sarah Hersey MBA, RAC, VP, Head of Translational Sciences & Diagnostics, BMSBMS	Moving Sequencing Into The Clinical Setting \| Panel Sivan Bercovici PhD, CTO, KariusKarius Heike Sichtig PhD, Dir., Foundation MedicineFoundation Medicine	Genomic Profiling Showcase Prasanth Reddy MD, MPH, FACP, Sr. VP & Global Head of Enterprise Oncology, LabcorpLabcorp	Clinical Dx Showcase Babak Alipanahi PhD, CSO, ExaiExai
Jan. 25 11:00 A.M.	Commercialization - Moving From Rare To Common \| Panel Chair: Matt Patterson Chairman, Vor BioVor Bio	Representation And Equity In Genomic Data \| Panel Chair: Karen Miga PhD, Assist. Prof., UCSCUCSC	Regulatory And Reimbursement Challenges For Precision Medicine \| Panel Chair: Cynthia Bens SVP, Public Policy, PMCPMC	Spatial Single-Cell Multi-Omics Chair: Michael Rhodes PhD, Sr. Dir., Advanced Applications, NanostringNanostring	AI and Data Sciences Showcase Martin Stumpe PhD, Chief of Artificial Intelligence, TempusTempus	Clinical Dx Showcase Matthew Baker PhD, CTO, Dxcover LtdDxcover Ltd
Jan. 25 11:15 A.M.	Commercialization - Moving From Rare To Common \| Panel Shankar Ramaswamy MD, Co-Founder, Chairman & CEO, Kriya TxKriya Tx	Representation And Equity In Genomic Data \| Panel Timothy Rebbeck PhD, Vincent L. Gregory Prof. of Cancer Prevention, Harvard U.Harvard U.	Regulatory And Reimbursement Challenges For Precision Medicine \| Panel Robert Dumanois Dir., Reimbursement Strategy, Thermo FisherThermo Fisher	Spatial Single-Cell Multi-Omics Christina Curtis PhD, Prof. of Medicine, StanfordStanford	AI and Data Sciences Showcase Martin Stumpe PhD, Chief of Artificial Intelligence, TempusTempus	Clinical Dx Showcase Matthew Baker PhD, CTO, Dxcover LtdDxcover Ltd
Jan. 25 11:30 A.M.	- \| Panel Sarah Glass MBA, SVP, UltragenyxUltragenyx Rahul Singhvi Sc.D., Co-founder & CEO, ResilienceResilience	Representation And Equity In Genomic Data \| Panel Keolu Fox PhD, Prof., UC San DiegoUCSD	Regulatory And Reimbursement Challenges For Precision Medicine \| Panel Kaska (Katarzyna) Kowanetz PhD, Dir., Global Regulatory Affairs, PfizerPfizer	Sequencing Techniques & Applications Track Josh Lauer Chief Commercial Officer, Ultima GenomicsUltima Genomics	AI and Data Sciences Showcase Anni Ahonen-Bishopp PhD, Solution Dir., Pharma & Research, BC PlatformsBC Platforms	Clinical Dx Showcase Andy Bredemeyer PhD, VP, Sci. Consultant, PierianPierian
Jan. 25 11:45 A.M.	Commercialization - Moving From Rare To Common \| Panel Andrew Lo PhD, Charles E. & Susan T. Harris Prof., MITMIT Mark Harrison PhD, Assoc. Prof., UBCUBC	Representation And Equity In Genomic Data \| Panel Malcolm John PhD, MPH, Medical Dir. of Health Equity, UCSFUCSF	Regulatory And Reimbursement Challenges For Precision Medicine \| Panel Elaine Katrivanos VP of Regulatory Affairs, TempusTempus Elizabeth Mansfield PhD, VP, RA, Foundation MedicineFoundation Medicine	Partnering For Health Emma Stanton MD, MBA, VP Clinical, Oxford NanoporeOxford Nanopore	AI and Data Sciences Showcase Benjamin Tan PhD, Scientist, ASTAR - I²RASTAR - I²R	Clinical Dx Showcase Andy Bredemeyer PhD, VP, Sci. Consultant, PierianPierian
Jan. 25 1:00 P.M.	Future Modalities \| Panel Chair: Shannon Muir PhD, Co-Dir. of PM, CA Initiative to Advance PMCA Initiative to Advance PM	Overcoming Barriers To Bringing Multi-Omics Into Clinical Practices \| Panel Chair: Russ Cucina MD, VP, Genetics & Genomics, & Chief Medical Information Officer, UCSF HealthUCSF Health	Early Cancer Detection 360 Degree View \| Panel Chair: Christian Wolfrum PhD, Head New Business Dev. & Planning, Siemens HealthineersSiemens Healthineers Stephan Brock PhD, CTO, Molecular HealthMolecular Health	How Will Cheap Genome Sequencing Impact Genomic Medicine \| Panel Chair: Euan Ashley MD, PhD, Assoc. Dean, StanfordStanford	AI and Data Sciences Showcase Eran Segal PhD, Computational Biology Prof., Weizmann Inst.Weizmann Institute	Clinical Dx Showcase Giuseppe Di Caro PhD, Assoc. Dir. Translational Research, Epic SciencesEpic Sciences
Jan. 25 1:15 P.M.	Future Modalities \| Panel Nadav Ahituv PhD, Prof., UCSFUCSF	Overcoming Barriers To Bringing Multi-Omics Into Clinical Practices \| Panel Amie Blanco Dir., Cancer Genetics & Prevention & Hereditary Cancer Programs, UCSFUCSF Peter DeVault VP, Genomics & Interoperability, EpicEpic	Early Cancer Detection 360 Degree View \| Panel Costanzo DiPerna MD, Thoracic Surgeon, CommonspiritCommonspirit Christian Eusemann PhD, VP Research & Innovation, Siemens HealthineersSiemens Healthineers	How Will Cheap Genome Sequencing Impact Genomic Medicine \| Panel Aleksandar Rajkovic MD, PhD, Chief Genomics Officer, UCSFUCSF	AI and Data Sciences Showcase Tim Guilliams PhD, CEO & Co-Founder, HealxHealx	Clinical Dx Showcase Ian Maurer CTO, GenomOncologyGenomOncology
Jan. 25 1:30 P.M.	Future Modalities \| Panel Amber Salzman PhD, CEO, Epic BioEpic Bio	Overcoming Barriers To Bringing Multi-Omics Into Clinical Practices \| Panel Kevin Haas PhD, Chief Technology Officer, Myriad GeneticsMyriad Genetics	Novel Clinical Trial Designs \| Panel Chair: Razelle Kurzrock MD, FACP, Ctr. Assoc. Dir., Prof., Medical College of WisconsinMedical College of Wisconsin	How Will Cheap Genome Sequencing Impact Genomic Medicine \| Panel Shawn Levy PhD, SVP Applications & Scientific Affairs, Element BiosciencesElement Biosciences David Bentley PhD, VP & Chief Scientist, IlluminaIllumina	AI and Data Sciences Showcase Jack DiGiovanna PhD, SVP, General Manager, Seven BridgesSeven Bridges	Clinical Dx Showcase Ian Maurer CTO, GenomOncologyGenomOncology
Jan. 25 1:45 P.M.	Future Modalities \| Panel Brett Staahl PhD, Co-Founder, VP of Platform, Scribe TxScribe Tx	Overcoming Barriers To Bringing Multi-Omics Into Clinical Practices \| Panel Jim Chen MD, Senior VP, Cancer Informatics, Tempus LabsTempus Labs	Novel Clinical Trial Designs \| Panel Jim Palma Executive Dir., TargetCancer FoundationTargetCancer Foundation	How Will Cheap Genome Sequencing Impact Genomic Medicine \| Panel Stacey Gabriel PhD, Chief Genomics Officer, Broad Inst.Broad Inst. Sean Hofherr PhD, Chief Operating Officer & Clinical Dir., Fabric GenomicsFabric Genomics	AI and Data Sciences Showcase Jack DiGiovanna PhD, SVP, General Manager, Seven BridgesSeven Bridges	Clinical Dx Showcase Chris Hall Pres., PersonalisPersonalis
Jan. 25 2:00 P.M.	Gene and Cell Therapies Track Michael Binkley PhD, Dir. of Engineering, OpenCellOpenCell	AI and Data Science in Clinical Practice Track Thomas Westerling-Bui PhD, VP of Americas, AiforiaAiforia Inc	Novel Clinical Trial Designs \| Panel Jason Sicklick MD, Prof. of Surgery & Pharmacology, UC San Diego HealthUCSD Health	Single-Cell, Spatial, And In Situ Technologies Chair: Dina Finan PhD, Senior Market Segment Manager, 10x Genomics10x Genomics	AI and Data Sciences Showcase Aaron Friedman PhD, Principal Product Manager, Amazon Web ServicesAWS	Clinical Dx Showcase Chris Hall Pres., PersonalisPersonalis
Jan. 25 2:15 P.M.	Cellular Rejuvenation Programming Hana El-Samad PhD, Prof., UCSF; SVP, UCSF/Altos LabsUCSF	Misaligned Incentives Across Public-Private Partnerships In Patient Health \| Panel Chair: Justin Wildsmith Head of Commercial Partnerships, SyntropySyntropy	Novel Clinical Trial Designs \| Panel Corrie Painter PhD, VP External Research & Partnerships, Precede BioPrecede Bio Laura Esserman MD, Dir., UCSF Breast Care Ctr., UCSFUCSF	Single-Cell, Spatial, And In Situ Technologies Carina Emery Sr Marketing Product Manager, Miltenyi BiotecMiltenyi Biotec	AI and Data Sciences Showcase Randal Goomer PhD, Sr. Global Advisory, AI/ML Healthcare & Life Science, Amazon Web ServicesAWS	Clinical Dx Showcase Seamus Kearney BEng, MSc., CEO, ARC RegulatoryARC Regulatory
Jan. 25 2:30 P.M.	Bioethics & Ethical Implications In Cell And Gene Therapies Hank Greely JD, Prof. of Law; Prof. by Courtesy of Genetics, StanfordStanford	Misaligned Incentives Across Public-Private Partnerships In Patient Health \| Panel Steve Goldstein MD, PhD, Vice Chancellor of Health Affairs, UC IrvineUC Irvine Ken Harris Head of Academic Medicine, Amazon Web ServicesAWS	Early Oncology Applications Track Matthew Goldberg MD, F.A.A.D., Medical Dir., Castle BiosciencesCastle Biosciences	Combining WGS With An AI-Based Tumor Enrichment Method Asaf Zviran PhD, CEO & CSO, C2i GenomicsC2i Genomics	Genomic Profiling Showcase George Sledge, Jr. MD, Executive VP & CMO, Caris Life SciencesCaris Life Sciences	Clinical Dx Showcase Seamus Kearney BEng, MSc., CEO, ARC RegulatoryARC Regulatory
Jan. 25 2:45 P.M.	Bioethics & Ethical Implications In Cell And Gene Therapies Q & A Questions from the AudienceQuestions from the Audience	Misaligned Incentives Across Public-Private Partnerships In Patient Health \| Panel Nelson D’Antonio Head of Biomedical Partnerships & Strategy, PalantirPalantir	Equity In Delivery Of Precision Cancer Care Through Community-Academic Partnerships Manali Patel MD, Assist. Prof., StanfordStanford	Combining WGS With An AI-Based Tumor Enrichment Method Asaf Zviran PhD, CEO & CSO, C2i GenomicsC2i Genomics	Genomic Profiling Showcase George Sledge, Jr. MD, Executive VP & CMO, Caris Life SciencesCaris Life Sciences	Clinical & Research Tools Showcase David Bourdon PhD, Dir., Assay Dev., Epic SciencesEpic Sciences
Jan. 25 3:30 P.M.	Patient Driven Therapies: The Challenges And Successes \| Panel Chair: Yael Weiss MD, PhD, CEO, Mahzi TxMahzi Tx	AI and Data Science in Clinical Practice Track Amrie Grammer PhD, COO/CSO, AMPEL BioSolutionsAMPEL BioSolutions	Challenges In Genomic Profiling Of Pediatric Cancers Chair: Andrew Kung MD, PhD, Chair, MSKCCMSKCC	Multi-Omics Approaches Supporting Clinical Translation \| Panel Chair: Cindy Lawley PhD, Dir., Population Health, OlinkOlink Erin Smith PhD, Principal Scientist, TakedaTakeda	Pharmacogenomics (PGx) Showcase Jeremy Stuart PhD, Chief Science Officer, Precision GeneticsPrecision Genetics	Clinical & Research Tools Showcase Corina Shtir PhD, CEO, Co-Founder, InterOmeInterOme Inc
Jan. 25 3:45 P.M.	Patient Driven Therapies: The Challenges And Successes \| Panel Terry Pirovolakis Founder, CureSPG50CureSPG50 Allyson Berent DVM, DACVIM, Chief Science Officer, FASTFAST	AI and Data Science in Clinical Practice Track Liat Dassa PhD, Immunology Team Lead, CytoReasonCytoReason	Challenges In Genomic Profiling Of Pediatric Cancers Christina Curtis PhD, Prof. of Medicine, StanfordStanford	Multi-Omics Approaches Supporting Clinical Translation \| Panel Christopher Whelan PhD, Dir., Neuroscience Data Science, J&JJ&J Si Wu PhD, Senior Bioinformatics Scientist II, AbbVieAbbVie	Pharmacogenomics (PGx) Showcase Jeremy Stuart PhD, Chief Science Officer, Precision GeneticsPrecision Genetics	Clinical & Research Tools Showcase Corina Shtir PhD, CEO, Co-Founder, InterOmeInterOme Inc
Jan. 25 4:00 P.M.	Emerging Gene Therapies For Epidermolysis Bullosa Peter Marinkovich MD, Assoc. Prof., StanfordStanford	AI and Data Science in Clinical Practice Track Ryan Ahern MD, CMO, TruvetaTruveta	Early Oncology Applications Track Solomon Diamond PhD, CEO, Lodestone BiomedicalLodestone Biomedical	Molecular Diagnosis With NGS For Neurological And Infectious Conditions Chair: Scott Rabuka Senior Dir., Molecular Products, DNA GenotekDNA Genotek	Microbial Profiling Showcase Brice Le Francois PhD, R&D Manager- Technology, DiversigenDiversigen	Clinical & Research Tools Showcase Scott Hutton VP, Collaborations, CDDCDD
Jan. 25 4:15 P.M.	Closing of the Track. Champagne & Hors D'oeuveres at Exhibit #C2026 at 5pm	A Framework For The Ethical Integration Of Precision Ai Into Healthcare Lisa Lehmann MD, PhD, Dir. of Bioethics, GoogleGoogle	Early Oncology Applications Track Jennifer Smith PhD, Founder, Pres. & CSO, PreCytePreCyte	Molecular Diagnosis With NGS For Neurological And Infectious Conditions Frank Middleton PhD, Prof., SUNY Upstate MedicalSUNY Upstate Medical U. Forrest Wright PhD, Dir. of Assay Dev., Quadrant BiosciencesQuadrant Biosciences	Microbial Profiling Showcase Brice Le Francois PhD, R&D Manager- Technology, DiversigenDiversigen	Clinical & Research Tools Showcase Scott Hutton VP, Collaborations, CDDCDD
Jan. 25 4:30 P.M.		Closing of the Track. Champagne & Hors D'oeuveres at Exhibit #C2026 at 5pm	City of Hope Precision Medicine Stephen Gruber MD, PhD, VP, City of Hope National Medical Ctr.; Medical Oncologist, City of HopeCity of Hope	Sequencing Techniques & Applications Track Lukasz Boryn PhD, Senior Bioinformatician, ArdigenArdigen	Digital Health Showcase Carla Balch CEO/Founder, SpesanaSpesana	Closing of the Track. Champagne & Hors D'oeuveres at Exhibit #C2026 at 5pm
Jan. 25 4:45 P.M.			Closing of the Track. Champagne & Hors D'oeuveres at Exhibit #C2026 at 5pm	Closing of the Track. Champagne & Hors D'oeuveres at Exhibit #C2026 at 5pm	Showcase Continues Kieran O'Kane Chief Commercial Officer, BiodesixBiodesix Stephen Kovacs DO, FCCP, Chief, Division of Pulmonary Medicine, UPMCUPMC

January 26

	Track 1	Track 2	Track 3	Track 4	Showcase Track S1	Showcase Track S2
January 26
Jan. 26 9:00 A.M.	Day2: Gene Modified Cell Therapies Track PMWC 2023 Luminary Award Ceremony Bruce Levine PhD, Barbara & Edward Netter Prof. in Cancer Gene Therapy, UPennUPenn	Day2: Real World Evidence Data Track Clinical Studies Using RWD \| Panel Chair: Aaron Kamauu MD, Founder & CEO, NavidenceNavidence Liora Schultz MD, Pediatric Oncologist, StanfordStanford	Day2: Women's Health Track PMWC 2023 Pioneer Award Ceremony Marcia L Stefanick PhD, Prof. of Medicine, StanfordStanford	Day2: Clinical Utility of Liquid Biopsies Track Session Continues Razelle Kurzrock MD, FACP, Ctr. Assoc. Dir., Prof., Medical College of WisconsinMedical College of Wisconsin Luis Diaz MD, Head, Division of Solid Tumor Oncology, MSKCCMSKCC	Day2: AI & Data Sciences, PGx, and Health Monitoring Digital Health Showcase Shawnnah Monterrey CEO, BeanStock VenturesBeanStock Ventures	Day2: Clinical Dx, and Clinical & Research Tools Clinical Dx Showcase Sandrine Miller-Montgomery PharmD, PhD, CEO, MicronomaMicronoma
Jan. 26 9:15 A.M.	Advance And Optimize Cell Therapies In Oncology \| Panel Chair: Sharon Benzeno PhD, Chief Commercial Officer, Immune Medicine, Adaptive BiotechAdaptive Biotech	Clinical Studies Using RWD \| Panel Farid Vij Pres. & GM, Patient Network & Data, InvitaeInvitae V. Scott Morris VP, Health Sciences, Change Healthcare (part of Optum)Change Healthcare part of Optum	Chronic Diseases In Women Chair: Marcia L Stefanick PhD, Prof. of Medicine, StanfordStanford	Non-Invasive Liquid Biopsy Techniques \| Panel Chair: Razelle Kurzrock MD, FACP, Ctr. Assoc. Dir., Prof., Medical College of WisconsinMedical College of Wisconsin	Pharmacogenomics (PGx) Showcase Avni Santani PhD, FACMG, CMO, LetsGetCheckedLetsGetChecked	Clinical Dx Showcase Daniel Series Chief Data Officer, InterVennInterVenn Bioscience
Jan. 26 9:30 A.M.	Advance And Optimize Cell Therapies In Oncology \| Panel Ira Mellman PhD, VP, Cancer Immunology, GenentechGenentech	Clinical Studies Using RWD \| Panel Sanket Dhruva MD, Assist. Prof. of Medicine, UCSFUCSF Motiur Rahman PhD, Senior Epidemiologist, Real World Evidence Analytics, FDAFDA	Chronic Diseases In Women Marina Sirota PhD, Assoc. Prof., UCSFUCSF	Non-Invasive Liquid Biopsy Techniques \| Panel Apostolia Maria Tsimberidou MD, PhD, Prof. of Medicine, UT - MD AndersonMD Anderson Cancer Ctr.	Sequencing Technologies Showcase Nicholas Gallerani PhD, Scientific Affairs, NuProbe USANuProbe USA	Clinical Dx Showcase Sungwon Lim PhD, CEO & Co-founder, ImpriMedImpriMed
Jan. 26 9:45 A.M.	Advance And Optimize Cell Therapies In Oncology \| Panel Sneha Ramakrishna MD, Instructor of Pediatrics in the Division of Hematology & Oncology, StanfordStanford Mark Selby MD, PhD, Co-founder & SVP, Immunology, Walking Fish TxWalking Fish Tx	Beyond The EHR: Acquisition Of RWD Types To Enable Precision Medicine \| Panel Chair: Riley Bove MD, Assoc. Prof., UCSFUCSF	Stem Cells, Preimplantation And Prenatal Genetics Chair: Akash Kumar MD, PhD, Chief Medical & Scientific Officer, MyOmeMyOme	Non-Invasive Liquid Biopsy Techniques \| Panel Mandana Kamgar MD, Assist. Prof. of Medicine, Medical College of WisconsinMedical College of Wisconsin	Sequencing Technologies Showcase Shawn Levy PhD, SVP, Applications & Scientific Affairs, Element BiosciencesElement Biosciences	Clinical Dx Showcase Sungwon Lim PhD, CEO & Co-founder, ImpriMedImpriMed
Jan. 26 10:00 A.M.	Advance And Optimize Cell Therapies In Oncology \| Panel Nick Haining BM, BCh, CSO, ArsenalBioArsenalBio Loic Vincent PhD, CSO, Affini-T TxAffini-T Tx	Beyond The EHR: Acquisition Of RWD Types To Enable Precision Medicine \| Panel Matthew Lungren MD, MPH, Chief Medical Information Officer, Microsoft (Nuance)Microsoft Anna Berry MD, SVP Biomarker Data & Lab Medicine, SyapseSyapse	Stem Cells, Preimplantation And Prenatal Genetics Teresa Sparks MD, Assoc. Prof., Maternal Fetal Medicine & Clinical Genetics, UCSFUCSF	Non-Invasive Liquid Biopsy Techniques \| Panel Mina Nikanjam MD, PhD, Medical Oncologist, UCSDUCSD Ash Alizadeh MD, PhD, Prof. of Medicine (Oncology); C.M.A, Stanford / ForesightStanford	Genomic Profiling Showcase Mark Van Oene Chief Operating Officer, PacBioPacBio	Clinical Dx Showcase Marija Plodinec PhD, CEO, Co-Founder, ARTIDIS, AGARTIDIS AG
Jan. 26 10:15 A.M.	Advance And Optimize Cell Therapies In Oncology \| Panel Warner Biddle SVP & Global Head of Commercial, Kite PharmaKite Pharma	Beyond The EHR: Acquisition Of RWD Types To Enable Precision Medicine \| Panel Vasu Chandrasekaran VP, Real-World Data & Analytics, OntadaOntada Ashley Brenton PhD, VP RWE & Genomics, Optum Life SciencesOptum Life Sciences	Stem Cells, Preimplantation And Prenatal Genetics Nathan Treff PhD, HCLD, Cofounder, CSO, & Clinical Laboratory Dir., Genomic PredictionGenomic Prediction	Clinical Utility of Liquid Biopsies Track Harmeet Dhani MD, MBA, MSc, Medical Dir., Biological DynamicsBiological Dynamics	Genomic Profiling Showcase Suma Shankar MD, PhD, Prof. & Chief, Genomic Medicine, UC DavisUC Davis	Clinical Dx Showcase Yipeng Wang MD, PhD, VP of Translational Medicine, BioFluidicaBioFluidica
Jan. 26 11:00 A.M.	Pioneering Cell Therapies In The Treatment Of Autoimmune Disorders \| Panel Chair: Carl June MD, PhD, Prof. of Immunotherapy; Dir., Ctr. for Cellular Immunotherapies; Dir., Parker Inst. for Cancer Immunotherapy, UPennUPenn	Data Linkage, Harmonization, And Quality \| Panel Chair: Vivek Rudrapatna MD, PhD, Assist. Prof., UCSFUCSF	Precision Health For Mothers And Babies Chair: David Stevenson MD, Harold K. Faber Prof. of Pediatrics, StanfordStanford	Liquid Biopsy Challenges And Limitations \| Panel Chair: Victor Lin MD, PhD, Medical Dir. of Clinical Research & Genetics, Mary Bird PerkinsMary Bird Perkins	Health Monitoring Showcase Brice Le Francois PhD, R&D Manager, DNAGenotek/NovosanisDNAGenotek/Novosanis	Clinical Dx Showcase Casey Riegler Senior Field Application Sci., TwistTwist Bioscience
Jan. 26 11:15 A.M.	Pioneering Cell Therapies In The Treatment Of Autoimmune Disorders \| Panel Leonard Dragone MD, PhD, CMO, Sonoma BioSonoma Bio	Data Linkage, Harmonization, And Quality \| Panel Adam Asare PhD, Chief Data Officer, QLHCQLHC Rohit Vashisht PhD, Clinical Research Data Scientist, UCSFUCSF	Precision Health For Mothers And Babies Aleksandar Rajkovic MD, PhD, Chief Genomics Officer, UCSFUCSF	Liquid Biopsy Challenges And Limitations \| Panel Maximilian Diehn MD, PhD, Division Chief of Radiation & Cancer Biology, StanfordStanford	Health Monitoring Showcase Oezlem Karalay PhD, Senior Scientist, QIAGENQIAGEN	Clinical Dx Showcase Casey Riegler Senior Field Application Sci., TwistTwist Bioscience
Jan. 26 11:30 A.M.	Pioneering Cell Therapies In The Treatment Of Autoimmune Disorders \| Panel James Chung MD, PhD, CMO, Kyverna TxKyverna Tx	Data Linkage, Harmonization, And Quality \| Panel Wanmei Ou VP, Product Life Sciences & Analytics Data Platform, OntadaOntada Dan Riskin MD, CEO, VerantosVerantos	Precision Health For Mothers And Babies Ivana Maric PhD, Senior Research Scientist, StanfordStanford	Liquid Biopsy Challenges And Limitations \| Panel Luis Diaz MD, Head, Division of Solid Tumor Oncology, MSKCCMSKCC	AI and Data Sciences Showcase Costas Tsougarakis VP of Life Science Solutions, FlywheelFlywheel	Clinical Dx Showcase Sivan Bercovici PhD, CTO, KariusKarius
Jan. 26 11:45 A.M.	Pioneering Cell Therapies In The Treatment Of Autoimmune Disorders \| Panel David Chang MD, CMO, Cabaletta BioCabaletta Bio Cristina Musselli MD, PhD, Head of Clinical Dev. Senior Dir., Abata TxAbata Tx	Data Linkage, Harmonization, And Quality \| Panel Mindy Hebert-DeRouen PhD, MPH, Research Scientist, UCSFUCSF	Precision Health For Mothers And Babies Nima Aghaeepour PhD, Assoc. Prof., StanfordStanford	Liquid Biopsy Challenges And Limitations \| Panel Emma Shtivelman PhD, Chief Scientist, Cancer CommonsCancer Commons Dana Dilbeck Global Market Access, AgilentAgilent	AI and Data Sciences Showcase Ganapati Srinivasa Chief Technology Officer, Omics Data AutomationOmics Data Automation	Clinical Dx Showcase Catherine Schnabel PhD, CSO, NucleixNucleix
Jan. 26 1:00 P.M.	Innovations In Cell Therapy Manufacturing \| Panel Chair: Bruce Levine PhD, Barbara & Edward Netter Prof. in Cancer Gene Therapy, UPennUPenn	Using RWE To Uncover And Address Health Disparities \| Panel Chair: Christopher Boone PhD, VP, Global Head of Health Economics & Outcomes Research, AbbvieAbbvie Robert Hiatt MD, PhD, Prof., UCSFUCSF	Precision Health For Mothers And Babies: Components Of Pregnancy Health Chair: Yoel Sadovsky MD, Executive Dir., Magee-Women's Research Inst.Magee Women's Research Inst.	Liquid Biopsy In Clinical Trials: Learnings And Covid Experience \| Panel Chair: Cindy Perettie Head of Molecular Labs, Roche DiagnosticsRoche Diagnostics	AI and Data Sciences Showcase Tim Wesselman CEO, RosalindRosalind	Clinical Dx Showcase Matthew Pink PhD, Sr. Dir., BD, BiodesixBiodesix
Jan. 26 1:15 P.M.	Innovations In Cell Therapy Manufacturing \| Panel Chris Holt Site Head & VP of Cell Therapy Manufacturing, BMSBMS Heidi Hagen Chief Technical Officer, Sonoma BioSonoma Bio	Using RWE To Uncover And Address Health Disparities \| Panel Alice Popejoy PhD, Assist. Prof., Dept. of Public Health Sciences, UC Davis HealthUC Davis Health	Precision Health For Mothers And Babies: Components Of Pregnancy Health Marina Sirota PhD, Assoc. Prof., UCSFUCSF	Liquid Biopsy In Clinical Trials: Learnings And Covid Experience \| Panel Alan Sandler MD, CMO, Mirati TxMirati Tx Yang Pan PhD, Executive Dir., Gilead SciencesGilead	AI and Data Sciences Showcase Rafael Rosengarten PhD, CEO, Genialis IncGenialis	Clinical Dx Showcase Brian Hashemi PhD, CEO & Chairman, NovigenixNovigenix SA
Jan. 26 1:30 P.M.	Innovations In Cell Therapy Manufacturing \| Panel Rahul Singhvi Sc.D., Co-founder & CEO, ResilienceResilience	Using RWE To Uncover And Address Health Disparities \| Panel Abasi Ene-Obong PhD, Founder, 54Gene54Gene	Precision Health For Mothers And Babies: Components Of Pregnancy Health Brice Gaudilliere MD, PhD, Assoc. Prof., StanfordStanford	Liquid Biopsy In Clinical Trials: Learnings And Covid Experience \| Panel Eric Peters PhD, Exec. Dir., Clinical Dx & Data Science, Translational Medicine, GenentechGenentech Andrew McKenzie PhD, VP, Personalized Medicine; Scientific Dir., Genospace, SCRISCRI	AI and Data Sciences Showcase Ryan Ramanujam PhD, MBA, Founder & Assoc. Prof., DatAnonDatAnon	Clinical & Research Tools Showcase Eleanor Matrullo Automation Program Manager, Watchmaker GenomicsWatchmaker Genomics
Jan. 26 1:45 P.M.	Innovations In Cell Therapy Manufacturing \| Panel Snehal Patel SVP, Head of Technical Operations, Sana BiotechnologySana Biotechnology	Using RWE To Uncover And Address Health Disparities \| Panel Vic Spain PhD, DVM, Global Real World Data Lead, Hematology & Respiratory, GenentechGenentech	Value Of Early Risk Prediction, Screening, & Digital Intervention In Pre-Term Birth Avoidance Chair: Leslie Saltzman DO, MBA, CMO, Ovia HealthOvia Health	Liquid Biopsy: Multi-Biomarker Class Approach To MCED Testing Tom Beer MD, CMO, Multi-Cancer Early Detection, Exact SciencesExact Sciences	AI and Data Sciences Showcase Ranit Aharonov PhD, Chief Technology Officer, Pangea BiomedPangea Biomed	Clinical & Research Tools Showcase Eleanor Matrullo Automation Program Manager, Watchmaker GenomicsWatchmaker Genomics
Jan. 26 2:00 P.M.	Patentability Of Immunotherapies: Latest Developments Janet Xiao PhD, Partner, Morrison FoersterMorrison Foerster	FDA Real-World Evidence Program Motiur Rahman PhD, Senior Epidemiologist, Real World Evidence Analytics, FDAFDA	Value Of Early Risk Prediction, Screening, & Digital Intervention In Pre-Term Birth Avoidance Sydney Strickland PhD, Discipline Dir., Biochemical Genetics & Maternal Serum Screening, LabcorpLabcorp	Liquid Biopsy: Multi-Biomarker Class Approach To MCED Testing Q & A Questions from the AudienceQuestions from the Audience	AI and Data Sciences Showcase Kenneth Bloom MD, Head of Pathology, NucleaiNucleai	Clinical & Research Tools Showcase Robert Snyder PhD, Assoc. Dir., Genomics, Precision for MedicinePrecision for Medicine
Jan. 26 2:15 P.M.	Investing In Gene Modified Cell Therapies \| Panel Chair: Karen Tuzman PhD, Head, Discovery & Preclinical Dev., BioCenturyBioCentury Abraham Bassan Principal, Samsara BioCapitalSamsara BioCapital	Fireside Chat \| Panel Chair: Vivek Rudrapatna MD, PhD, Assist. Prof., UCSFUCSF	Reproductive Aging \| Panel Chair: Aleksandar Rajkovic MD, PhD, Chief Genomics Officer, UCSFUCSF Nikolina Lauc CEO, GlycanAge LTDGlycanAge LTD	Liquid Biopsy For Early Cancer Detection \| Panel Chair: Priti Hegde PhD, CSO, Foundation MedicineFoundation Medicine Daniel Kim PhD, Assist. Prof., UC Santa CruzUCSC	AI and Data Sciences Showcase Michael Wilson CEO & Co-founder, DrugBankDrugBank	Clinical & Research Tools Showcase Mike Sheldon PhD, Sr. Dir., Sci. Affairs, SampledSampled
Jan. 26 2:30 P.M.	Investing In Gene Modified Cell Therapies \| Panel Robert Lin PhD, VP Translational Sciences, UPMC EnterprisesUPMC Enterprises Yvonne Yamanaka PhD, Principal, venBiovenBio	Fireside Chat \| Panel Hilary Marston MD, M.P.H., CMO, FDAFDA	Reproductive Aging \| Panel Diana Laird PhD, Prof., UCSFUCSF Jennifer Garrison PhD, Assist. Prof.; Co-Founder & Dir., Buck Inst. GCRLEBuck Inst. GCRLE	Liquid Biopsy For Early Cancer Detection \| Panel Mike Nolan MBA, CEO, FreenomeFreenome Jeffrey Venstrom MD, CMO, GRAILGRAIL	AI and Data Sciences Showcase Chris Gessner PhD, Health & Life Sciences Solutions Dir., KATANA GRAPHKATANA GRAPH	Clinical & Research Tools Showcase Martis Cowles PHD, CBO, EpiCypherEpiCypher
Jan. 26 2:45 P.M.	Investing In Gene Modified Cell Therapies \| Panel Brian Daniels MD, Partner, 5AM Ventures5AM Ventures	Fireside Chat \| Panel Atul Butte MD, PhD, Inst. Dir. & Distinguished Prof., UCSFUCSF	Reproductive Aging \| Panel Christian Kramme PhD, VP Cellular Engineering, GametoGameto	Liquid Biopsy For Early Cancer Detection \| Panel Lon Castle MD, Assoc. CMO, PM, eviCore healthcareeviCore healthcare Tom Beer MD, CMO, Multi-Cancer Early Detection, Exact SciencesExact Sciences Kathryn Phillips PhD, Prof. & Founding Dir., UCSF TRANSPERSUCSF TRANSPERS	AI and Data Sciences Showcase Chris Gessner PhD, Health & Life Sciences Solutions Dir., KATANA GRAPHKATANA GRAPH	Clinical & Research Tools Showcase Dan Harma MBA, CCO, Pillar BiosciencesPillar Biosciences
Jan. 26 3:30 P.M.	Leveraging Data Sets To Inform Future Drug Discovery And Development \| Panel Chair: Jason Coloma PhD, MBA, CEO, Maze TxMaze Tx	From Real World to Regulatory-Grade: Navigating the Evidence Chasm \| Panel Chair: Sheila Walcoff JD, CEO & Founder, Goldbug StrategiesGoldbug Strategies	Achieving Equity In Precision Medicine Aida Habtezion MD, MSc, FRCPC, AGAF, CMO & Head, Worldwide Medical & Safety, Pfizer IncPfizer	Liquid Biopsy For Minimal Residual Disease \| Panel Chair: Minetta Liu MD, CMO of Oncology, NateraNatera	Illumina Accelerator Showcase Amanda Cashin PhD, Co-Founder & Head, Illumina AcceleratorIllumina Accelerator	Clinical Dx Showcase Atul Sharan MBA, Pres. & CEO, CellMax LifeCellMax Life
Jan. 26 3:45 P.M.	Leveraging Data Sets To Inform Future Drug Discovery And Development \| Panel Peter DiLaura Chief Business & Strategy Officer, Sonoma BioSonoma Bio Daniel Kirouac PhD, Dir. of System Biology, Notch TxNotch Tx	From Real World to Regulatory-Grade: Navigating the Evidence Chasm \| Panel Elaine Katrivanos VP of Regulatory Affairs, TempusTempus Terry Myerson CEO, TruvetaTruveta	Sex Differences Chair: C Noel Bairey Merz MD, Dir., Barbra Streisand Women's Heart Ctr., Cedars-Sinai Med Ctr.Cedars Sinai Medical Ctr.	Liquid Biopsy For Minimal Residual Disease \| Panel Laura J van 't Veer PhD, Inventor, MammaPrint; Prof. of Laboratory Medicine, Dir. Applied Genomics, UCSFUCSF Peter Bach MD, CMO, Delfi DiagnosticsDelfi Diagnostics	Illumina Accelerator Showcase Candler Paige CEO, DOLOROMICSDOLOROMICS	Clinical & Research Tools Showcase Kaitlin McCarthy Lead Dev. & App. Sci., LaunchworksLaunchworks
Jan. 26 4:00 P.M.	Leveraging Data Sets To Inform Future Drug Discovery And Development \| Panel Kwame Okrah PhD, Assoc. Dir., Parker Inst.Parker Inst.	From Real World to Regulatory-Grade: Navigating the Evidence Chasm \| Panel Kathy Hibbs JD, Chief Administrative Officer, 23andMe23andMe	Sex Differences Danit Ariel MD, Clinical Assist. Prof., StanfordStanford	Liquid Biopsy For Minimal Residual Disease \| Panel Joshua Cohen Co-founder & Chief Innovation Officer, Haystack OncologyHaystack Oncology Susan Bobulsky MBA, SVP of Diagnostics, Adaptive BiotechAdaptive Biotech	Illumina Accelerator Showcase Tara deBoer PhD, Founder, CEO, BioAmp DiagnosticsBioAmp Diagnostics	Clinical & Research Tools Showcase Tamas Rujan Head Genedata Profiler, Genedata AGGenedata AG
Jan. 26 4:15 P.M.	Leveraging Data Sets To Inform Future Drug Discovery And Development \| Panel Nick Haining BM, BCh, CSO, ArsenalBioArsenalBio	From Real World to Regulatory-Grade: Navigating the Evidence Chasm \| Panel Michael Ryan JD, Partner, McDermott WillMcDermott Will	Women's Health Track Amrie Grammer PhD, COO/CSO, AMPEL BioSolutionsAMPEL BioSolutions	Clinical Utility of Liquid Biopsies Track Varsha Rao PhD, Dir. of Clinical Affairs & Partnerships, Claret BioscienceClaret Bioscience	Illumina Accelerator Showcase Michael Becich CEO, Cache DNACache DNA	Clinical & Research Tools Showcase Ted Snelgrove MBA, CEO, FormaPathFormaPath
Jan. 26 4:30 P.M.	Closing of the Track	Closing of the Track	Closing of the Track	Clinical Utility of Liquid Biopsies Track Jasmine Zhou PhD, Prof. & Co-founder, EarlyDiagnosticsEarlyDiagnostics	Closing of the Track	Clinical Dx Showcase Mithun Shah MD,Oncology Consult, CanCertainCanCertain Limited

January 27

	Track 1	Track 2	Track 3	Track 4	Showcase Track S1	Showcase Track S2
January 27
Jan. 27 9:00 A.M.	Day3: Pharmacogenomics Track PMWC 2023 PGx Award Ceremony Dan Roden MD, SVP for Personalized Medicine, VUMCVUMC Kelly Caudle PharmD, PhD, BCPS, FCCP, Clinical Pharmacogenetics Implementation Consortium (CPIC) Co-PI & Dir., St. Jude Children's Research HospitalSt. Jude	Day3: AI & Data Sciences in Drug Discovery & Clinical Research PMWC 2023 Award Ceremony Gad Getz PhD, Dir., Cancer Genome Analysis & Prof. of Pathology, Broad Inst.Broad Inst.	Day3: Population Scale Omics Track Session Continues David Bentley PhD, VP & Chief Scientist, IlluminaIllumina	Day3: Imaging Applications Track Session Continues Lea T. Grinberg MD, PhD, John Douglas French Alzheimer Foundation Endowed Prof., UCSFUCSF Daniela Ushizima PhD, Staff Scientist, Affiliate Faculty, Data Scientist, LBNL, UCSFUCSF	Day3: AI & Data Sciences, Emerging Tx, and Genomic & Microbial Profiling Microbial Profiling Showcase Nur Hasan PhD, CEO, EzBiomeEzBiome	Day3: Clinical Dx and Clinical & Research Tools Clinical Dx Showcase Nir Friedman PhD, Hebrew UniversityHebrew U.
Jan. 27 9:15 A.M.	Fireside Chat \| Panel Chair: Mary Relling PharmD, Endowed Chair in Pharma Sciences, St. JudeSt. Jude	Keynote Gad Getz PhD, Dir., Cancer Genome Analysis & Prof. of Pathology, Broad Inst.Broad Inst.	Learnings And Advancements Of Population Studies \| Panel Chair: Sharon Terry CEO, Genetic AllianceGenetic Alliance	Pattern Recognition And Content Quantification In Early-Stage Disease Diagnosis \| Panel Chair: Daniela Ushizima PhD, Staff Scientist, Affiliate Faculty, Data Scientist, LBNL, UCSFUCSF	Microbial Profiling Showcase Christopher Smith General Manager, One CodexOne Codex	Clinical Dx Showcase Marvin Weinstein PhD, CSO, Quantum InsightsQuantum Insights
Jan. 27 9:30 A.M.	Fireside Chat \| Panel Dan Roden MD, SVP for Personalized Medicine, VUMCVUMC	How Healthcare Can Solve Its Data Problem Rod Tarrago MD, Healthcare Executive Advisor, Amazon Web ServicesAWS	Learnings And Advancements Of Population Studies \| Panel David Bentley PhD, VP & Chief Scientist, IlluminaIllumina	Pattern Recognition And Content Quantification In Early-Stage Disease Diagnosis \| Panel Lea T. Grinberg MD, PhD, John Douglas French Alzheimer Foundation Endowed Prof., UCSFUCSF	Microbial Profiling Showcase Heidi Hau PhD, VP of Scientific Affairs & Partnerships, Clinical MicrobiomicsClinical Microbiomics	Clinical Dx Showcase Jhana Hendrickx PhD, Sr. Sci., Clin. Affairs, NovosanisNovosanis
Jan. 27 9:45 A.M.	Pharmacogenomics Keynote Kelly Caudle PharmD, PhD, BCPS, FCCP, Clinical Pharmacogenetics Implementation Consortium (CPIC), Co-PI & Dir., St. Jude Children's Research HospitalSt. Jude	How Healthcare Can Solve Its Data Problem Rod Tarrago MD, Healthcare Executive Advisor, Amazon Web ServicesAWS	Learnings And Advancements Of Population Studies \| Panel Robert Wildin MD, Assoc. Prof. Pathology & Laboratory Medicine & Pediatrics (Genetics), U. of Vermont HealthU. of Vermont Health Andrea Ganna PhD, FIMM-EMBL Group Leader, FIMMFIMM	Pattern Recognition And Content Quantification In Early-Stage Disease Diagnosis \| Panel Suzanne Baker PhD, Computational Staff Scientist, Lawrence Berkeley LabLawrence Berkeley Lab	Emerging Therapeutics Showcase Tito Serafini PhD, Founder & Chief Strategy Officer, AtrecaAtreca	Clinical Dx Showcase Michelle Perugini PhD, PharmD, CEO, PresagenPresagen
Jan. 27 10:00 A.M.	The Evolution Of Value Positioning In PGx: A Fireside Chat \| Panel Chair: Damon Hostin Lead, Healthcare Market Access, IlluminaIllumina	Remote Health Monitoring Using Microsampling And Wearables Michael Snyder PhD, Chair, Dept. of Genetics, StanfordStanford	Learnings And Advancements Of Population Studies \| Panel Slavé Petrovski PhD, VP, AstraZenecaAstraZeneca Alexander Charney MD, PhD, Dir. of Charles Bronfman Inst. of Personalized Medicine, Mount SinaiMount Sinai	Second Phase Of AI Imaging Is Clinical Validation Sean Khozin MD, M.P.H., Affiliate, MITMIT	Emerging Therapeutics Showcase Anil Narasimha PhD, CEO, MekonosMekonos	Clinical Dx Showcase Mathias Ehrich MD, CMO, Juno DXJuno DX
Jan. 27 10:15 A.M.	The Evolution Of Value Positioning In PGx: A Fireside Chat \| Panel Howard McLeod PharmD, Executive Clinical Dir. - Precision Health, Intermountain HealthcareIntermountain Health	Remote Health Monitoring Using Microsampling And Wearables Michael Snyder PhD, Chair, Dept. of Genetics, StanfordStanford	Precision Medicine In Understudied Populations Aimé Lumaka MD, PhD, Coordinator Genomic Medicine in Wallonia, CHU LiègeCHU Liège	Large-Scale Spatial Omics Imaging Analysis To Decipher The Tumor Microenvironment Joseph Lehar PhD, SVP R&D Strategy, OwkinOwkin	Health Monitoring Showcase Jin Lee PhD, Dir. of Digital Health, Astellas Pharma, IncAstellas Pharma	Clinical Dx Showcase Chris Dingman MBA, CCO, OncoHostOncoHost
Jan. 27 11:00 A.M.	Laboratory Testing And Reports Chair: Kristy Crooks PhD, FACMG, Assoc. Prof. of Pathology, U. of Colorado Anschutz Medical CampusUniv. of Colorado	NLP Applications To Parse Unstructured Medical Text Chair: William Oh MD, CMO, Prostate Cancer FoundationProstate Cancer Foundation	Precision Medicine In Understudied Populations Ryan Taft PhD, VP Scientific Research, IlluminaIllumina	Latest Achievement In AI Imaging Technology In The Area Of Radiology And Pathology Chair: Lars Costers Product Manager, icometrixicometrix	AI and Data Sciences Showcase Bryant Fields Senior Dir., Integrated Evidence, MedidataMedidata	Clinical Dx Showcase Marcia Grskovic PhD, COO, CareDxCareDx
Jan. 27 11:15 A.M.	Laboratory Testing And Reports Ann Moyer MD, PhD, Molecular Genetic Pathologist, Mayo ClinicMayo Clinic	NLP Applications To Parse Unstructured Medical Text Rong Chen PhD, Chief Health Informatics Officer, Sema4Sema4	Building Future Precision Care In Qatar Chair: Khalid Fakhro PhD, CRO, Sidra MedicineSidra Medicine	Latest Achievement In AI Imaging Technology In The Area Of Radiology And Pathology Joachim Schmid PhD, VP, R&D Spatial Informatics & AI, NanoStringNanoString	AI and Data Sciences Showcase Amrie Grammer PhD, COO/CSO, AMPEL BioSolutionsAMPEL BioSolutions	Clinical Dx Showcase Sandra Jernström PhD, Co-founder & CSO, OkomeraOkomera
Jan. 27 11:30 A.M.	Laboratory Testing And Reports Stuart Scott PhD, Prof., StanfordStanford	Improving The Probability Of Trial And Regulatory Success \| Panel Chair: Elizabeth Lamont MD, Senior Medical Dir., MedidataMedidata Dawn Barry Pres. & Co-Founder, LunaLuna	Building Future Precision Care In Qatar Ziyad H Hijazi MD, CMO, Sidra MedicineSidra Medicine	Latest Achievement In AI Imaging Technology In The Area Of Radiology And Pathology Fedaa Najdawi MD, Dir. of Pathology, PathAIPathAI	AI and Data Sciences Showcase Neel Madhukar PhD, CEO, Co-Founder, OneThree BiotechOneThree Biotech	Clinical Dx Showcase George Cardoza CEO, AccuraGenAccuraGen
Jan. 27 11:45 A.M.	Implementation Of PGx At UCSF Bani Tamraz PharmD, PhD, Assoc. Prof. Dept. of Clinical Pharmacy, UCSFUCSF	Improving The Probability Of Trial And Regulatory Success \| Panel Jacob Aptekar MD, PhD, VP Trial Design Solutions, MedidataMedidata Peter Bach MD, CMO, Delfi DiagnosticsDelfi Diagnostics	Building Future Precision Care In Qatar Edison Liu MD, Pres. & CEO, The Jackson LabsThe Jackson Labs	Latest Achievement In AI Imaging Technology In The Area Of Radiology And Pathology Nurit Paz-Yaacov PhD, CSO, ImageneImagene	Genomic Profiling Showcase Ivan Liachko PhD, CEO/CSO, Phase GenomicsPhase Genomics	Clinical Dx Showcase Young Seok Ju MD, PhD, Co-Founder, Genome InsightGenome Insight
Jan. 27 1:00 P.M.	From Economics To Reimbursement \| Panel Chair: Sara Rogers PharmD, Pres., ASPASP	AI/ML Applications For Patient Outcomes Prediction And Clinical Decision Support \| Panel Chair: Alex Sherman Principal Assoc. in Neurology, Harvard Medical SchoolHarvard Medical School	Challenges And Opportunities For National Precision Medicine Initiatives \| Panel Chair: Alessandro Riccombeni PhD, MBA, National Genomics Officer, Microsoft UKMicrosoft UK	Latest Achievement In AI Imaging Technology In The Area Of Radiology And Pathology Neil Weisenfeld PhD, Principal Scientist, 10x Genomics10x Genomics	AI and Data Sciences Showcase Jeremy Woods MD, PM Dir., Valley Children's HealthcareValley Children's Healthcare	Clinical Dx Showcase Donna Russell Co-founder & CEO, Precia GroupPrecia Group
Jan. 27 1:15 P.M.	From Economics To Reimbursement \| Panel Stirling Bryan PhD, Prof. / CSO, UBCUBC	AI/ML Applications For Patient Outcomes Prediction And Clinical Decision Support \| Panel Indu Navar MSCS, CEO, EverythingALSEverythingALS	Challenges And Opportunities For National Precision Medicine Initiatives \| Panel Catalina Lopez-Correa MD, PhD, CSO, Genome CanadaGenome Canada Khalid Fakhro CRO, Sidra MedicineSidra Medicine	Imaging Applications Track Omid Moghadam Chairman of the Board, RapidRapid	Sequencing Technologies Showcase Ramin Khaksar PhD, CSO, Clear LabsClear Labs	Clinical & Research Tools Showcase Chris Moxham PhD, CSO, RarebaseRarebase
Jan. 27 1:30 P.M.	From Economics To Reimbursement \| Panel Gabriel Bien-Willner MD, PhD, FCAP, Chief Medical Dir., Palmetto GBAPalmetto GBA Ray Stultz Product Dir. of Pharmacogenomics, Optum RxOptum Rx	AI/ML Applications For Patient Outcomes Prediction And Clinical Decision Support \| Panel Jacob Donoghue MD, PhD, CEO, Beacon BiosignalsBeacon Biosignals	Framework To Improve The Translation Of Genomics Into The Clinic \| Panel Chair: Kathleen Barnes PhD, SVP Population Genomics Health, Tempus LabsTempus Labs	AI In Radiology & Pathology Applications (Clinical Research) Chair: Mirabela Rusu PhD, Assist. Prof., StanfordStanford	Emerging Therapeutics Showcase Robert Hayes PhD, CSO , ImmusoftImmusoft	Clinical & Research Tools Showcase Tim Fugmann PhD, CSO & Co-Founder, AlitheaAlithea Bio UG
Jan. 27 1:45 P.M.	Policy Efforts To Address Barriers To PGx Adoption Chair: Kristine Ashcraft Medical Affairs Dir., Pharmacogenomics, InvitaeInvitae	AI/ML Applications For Patient Outcomes Prediction And Clinical Decision Support \| Panel Marie Abele Bind PhD, Biostatistician, MGH/HMSMGH/HMS	Framework To Improve The Translation Of Genomics Into The Clinic \| Panel Carlos Bustamante MD, Founder, Galatea Bio IncGalatea Bio Inc	AI In Radiology & Pathology Applications (Clinical Research) Saeed Hassanpour PhD, Assoc. Prof., DartmouthDartmouth	Pharmacogenomics (PGx) Showcase Mikhail Zastrozhin MD, PhD, MPH, Postdoctoral Scholar, UCSFUCSF	Clinical & Research Tools Showcase Thomas Klein Founder & CEO, Pirche AGPirche AG
Jan. 27 2:00 P.M.	Policy Efforts To Address Barriers To PGx Adoption Pam Traxel SVP, ACS CANACS CAN	Fair Data Approaches To Make Data Usable, Accessible, And Findable Bhavesh Patel PhD, Assist. Prof. of Research, Calmi2Calmi2	Framework To Improve The Translation Of Genomics Into The Clinic \| Panel Ora Gordon MD, Regional Medical Dir., Clinical Genetics & Genomics Program; Clinical Dir., Population Genomics Program, ProvidenceProvidence Abasi Ene-Obong PhD, Founder, 54Gene54Gene	AI In Radiology & Pathology Applications (Clinical Research) Jeanne Shen MD, Assist. Prof. of Pathology, StanfordStanford	Digital Health Showcase Joshua Resnikoff CEO, TMA Precision HealthTMA Precision Health	Clinical Dx Showcase Venkata Yellapantula PhD, Assist. Dir. of Bioinfo., CHLAChildren's Hospital LA
Jan. 27 2:15 P.M.	PGx Practice Liability Chair: Daniel Hertz PhD, PharmD, Assist. Prof., U. of MichiganU. of Michigan	The Pharma Informatics Ecosystem \| Panel Chair: Maria Karasarides PhD, VP, Medical Oncology, BMSBMS	Identifying Relationships Between Disparate Data Sets To Monitor And Control Pathogen Outbreak \| Panel Chair: Charles Chiu MD, PhD, Prof., Laboratory Medicine & Medicine/Infectious Diseases, UCSFUCSF	AI In Radiology & Pathology Applications (Clinical Research) Pratik Mukherjee MD., PhD., Prof., Dep. Radiology & Biomedical Imaging, UCSFUCSF
Jan. 27 2:30 P.M.	PGx Practice Liability Karen Merritt Patient Advocate, AUDTAUDT	The Pharma Informatics Ecosystem \| Panel Colin Hill CEO, Co Founder, AitiaAitia	Identifying Relationships Between Disparate Data Sets To Monitor And Control Pathogen Outbreak \| Panel Amy Kirby PhD, National Wastewater Surveillance System Program Lead, CDCCDC	Imaging Applications Track Amanda Hanson PM Dir., Spartanburg RegionalSpartanburg Regional
Jan. 27 2:45 P.M.	PGx Practice Liability Anthony Morreale PharmD, Assoc. Chief Consultant Clinical Pharmacy, VA, San DiegoUnited States Dept. of Veterans Affairs	The Pharma Informatics Ecosystem \| Panel Subha Madhavan PhD, VP & Head of Clinical AI/ML, Worldwide R&D, PfizerPfizer Christine Bakan Global Head, Computational Science & Informatics Research & Dev., Roche / GenentechRoche / Genentech	Identifying Relationships Between Disparate Data Sets To Monitor And Control Pathogen Outbreak \| Panel Smruthi Karthikeyan PhD, Assist. Prof., Engineering, Applied Science, William Hurt Scholar, CaltechCaltech	Imaging Applications Track Amanda Hanson PM Dir., Spartanburg RegionalSpartanburg Regional
Jan. 27 3:30 P.M.	Diversity, Equity, And Inclusion In Pharmacogenomics Implementation Chair: Carlos Bustamante MD, Founder, Galatea Bio IncGalatea Bio Inc	AI & Data Sciences in Drug Discovery & Clinical Research Steven Van Vooren PhD, Head of Product Marketing, UgenTecUgentec	Increasing Diversity In Population Studies Manuel Rivas PhD, Assist. Prof., StanfordStanford	Closing of the Track	Closing of the Track	Closing of the Track
Jan. 27 3:45 P.M.	Diversity, Equity, And Inclusion In Pharmacogenomics Implementation Kathy Giacomini PhD, Dean, School of Pharmacy, UCSFUCSF	AI & Data Sciences in Drug Discovery & Clinical Research Janusz Dutkowski PhD, CEO & Founder, Data4CureData4Cure	The Missing Diversity In Human Epigenomic Studies Charles Breeze PhD, Research Scholar, NCINCI
Jan. 27 4:00 P.M.	Implementation Of PGx Program & PGx Clinic Services In a Large Rural Healthcare Setting April Schultz PharmD, Dir., Operations & Pharmacogenomic Services, SanfordSanford	Closing of the Track	The Transition From Genomics To Phenomics In Precision Population Health Lee Hood MD, PhD, CEO/Founder, Phenome Health & Chief Strategy Officer/Prof., Inst. for Systems BiologyPhenome Health